Trending...
- wine2wine Vinitaly Business Forum 2025: Equipping the wine industry with the tools to face an uncertain future - 169
- City of Chicago Announces Landmark Global Settlement To Resolve Wrongful Conviction Lawsuits Tied To Ronald Watts
- Riviera Marketing & MAZ6R CLAN: A Creative Response to Tragedy!
TEMECULA, Calif. - illiNews -- 16Revolutionary Anti-Aging Breakthrough Unveiled: Telomere Technology and Telos95 Offer Promising Results
TEMECULA, CA – July 16, 2024 - In a groundbreaking development poised to redefine anti-aging treatments, researchers at the Salk Institute have introduced cutting-edge Telomere Technology alongside Telos95®, a clinically proven anti-aging supplement targeting cellular aging. Telos95® consists of a plant-based blend of highly therapeutic polyphenols naturally isolated from grapevine and organic olive leaf.
Telos95®'s phytochemical compounds fight free radicals, nourishing cells with nutrients that promote telomere and cellular longevity, effectively slowing down the aging process of healthy cells. This supplement not only halts the shortening of telomeres but has been shown to lengthen them, reducing cellular age by an average of 7.43 years in just 6 months.
Abdul Alkayali, Vice President of Sales at Longevity by Nature, explains, "Our clinical studies demonstrate that Telos95® protects telomeres, slows cellular aging, and enhances longevity. By harnessing the power of natural polyphenols, we aim to redefine how we approach aging and age-related illnesses."
More on illi News
Telomere Technology, in conjunction with Telos95®, offers potential benefits in reducing the need for therapies to treat age-related illnesses such as cancer, cardiovascular problems, eye diseases, and inflammatory conditions. Moreover, Telos95® can be prescribed to insurance customers who have undergone telomere testing, showing promise in stopping or reversing telomere shortening with regular use.
"In our human study," Abdul Alkayali continues, "participants who consumed Telos95® daily experienced significant reductions in their TeloYear Age, demonstrating the supplement's efficacy in promoting cellular health and wellness."
For more information on Telos95® visit Telos95: Telomere Lengthening Anti-Aging Supplement (longevitybynature.biz), and on Telomere Technology, visit Anti-Aging Telomere Tech | Worldhealth.net Anti-Aging News.
TEMECULA, CA – July 16, 2024 - In a groundbreaking development poised to redefine anti-aging treatments, researchers at the Salk Institute have introduced cutting-edge Telomere Technology alongside Telos95®, a clinically proven anti-aging supplement targeting cellular aging. Telos95® consists of a plant-based blend of highly therapeutic polyphenols naturally isolated from grapevine and organic olive leaf.
Telos95®'s phytochemical compounds fight free radicals, nourishing cells with nutrients that promote telomere and cellular longevity, effectively slowing down the aging process of healthy cells. This supplement not only halts the shortening of telomeres but has been shown to lengthen them, reducing cellular age by an average of 7.43 years in just 6 months.
Abdul Alkayali, Vice President of Sales at Longevity by Nature, explains, "Our clinical studies demonstrate that Telos95® protects telomeres, slows cellular aging, and enhances longevity. By harnessing the power of natural polyphenols, we aim to redefine how we approach aging and age-related illnesses."
More on illi News
- Chicago: O'Hare International Airport Sets All-Time Passenger Record in July 2025
- The Hidden Triggers of Foreclosure Most Families Don't See Coming
- Strategic Partnerships with Defiant Space Corp and Emtel Energy USA Powerfully Enhance Solar Tech Leader with NASA Agreements: Ascent Solar $ASTI
- 120% Revenue Surge with Four Straight Profitable Quarters Signal a Breakout in the Multi-Billion Dollar Homebuilding Market: Innovative Designs $IVDN
- Leading Venture Capital Firms Recognize Wzzph Exchange's Technical Architecture and Security Framework as Industry Benchmark
Telomere Technology, in conjunction with Telos95®, offers potential benefits in reducing the need for therapies to treat age-related illnesses such as cancer, cardiovascular problems, eye diseases, and inflammatory conditions. Moreover, Telos95® can be prescribed to insurance customers who have undergone telomere testing, showing promise in stopping or reversing telomere shortening with regular use.
"In our human study," Abdul Alkayali continues, "participants who consumed Telos95® daily experienced significant reductions in their TeloYear Age, demonstrating the supplement's efficacy in promoting cellular health and wellness."
For more information on Telos95® visit Telos95: Telomere Lengthening Anti-Aging Supplement (longevitybynature.biz), and on Telomere Technology, visit Anti-Aging Telomere Tech | Worldhealth.net Anti-Aging News.
Source: Longevity by Nature
0 Comments
Latest on illi News
- NKSCX Responds to "Coordinated Smear Campaign" as Anonymous Critics Emerge Following Regulatory Milestones
- Broadway Gala Honored Also an Italian
- $ONI Listed on MEXC as ONINO Powers Europe's Tokenization Engine Into Public Platform Launch
- AZETHIO Crypto Exchange Whitepaper Reveals MPC-Secured Infrastructure Processing 1.2 Million Transactions Per Second
- CELOXFI Platform Demonstrates Advanced Security Architecture and Regulatory Framework
- Work 365 Launches PV 3.0: The Keystone Power App for Microsoft CSPs
- Local consultant shows small businesses how to turn red tape into real money
- CU Aerospace DUPLEX Satellite headed to the ISS on SpaceX NG-23 Mission
- Tour Napa Like a Local: Vines of Napa Valley Wine Passport AKA Vine Pass Unlocks Hidden Gems
- Mather Goes Bold to Challenge Society's Views on Aging
- Dental Surgical Center Accepts Sedation Patients with Medicaid for MD, WV, PA and DC
- MooreSuccess Gaming Launches Digi 995: Color Protocol – A Futuristic Coloring Experience
- A New Era in Healthcare Marketing
- Chicago: Mayor Brandon Johnson Signs 'Right to Protest' Executive Order
- Sloan's Lake Dental Launches New Website to Enhance Patient Experience and Access to Modern Dental Care
- Only 3 Weeks Left till the Start of the OpenSSL Conference 2025
- InventHelp Inventor Develops Portable Sit-On-Scale (CLR-320)
- ENTOUCH Completes $50 million Funding Round
- Teaming Agreement with Emtel Energy USA to Advance Thin-Film PV Energy Storage Capabilities; NASA agreements for Solar Space Tech; Ascent Solar $ASTI
- Nebuvex Acknowledges Platform "Too Secure" for Anonymous Traders; Institutional Investors Disagree